The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Mar 17, 2006

BY, Thankyou very much. Our physician has prescribed Nevirapine and it is being added to daily regimen. If you don't mind taking some more time of yours, can you please tell me your realistic impresssion of HIV vaccine progress and availabilty timeline ? Also, does HIV+ folks ever become non-tranmsitters ?

Thank you.

Response from Dr. Young

Thanks for your follow up.

I'm happy to hear that your doctor has started a three-drug regimen. Make sure to get the appropriate follow up to make sure that the liver functions are good.

As for vaccine-- I'm not wildly optimistic about a therapeutic or preventive vaccine any time in the near future. This shouldn't be taken as disinterest, but rather that what I've seen is still a long way from prime time.

Lastly, no, I wouldn't say that HIV+ patients ever become non- (read zero risk) transmitters. Treatment for HIV (if viral load is undetectable) does reduce the risk significantly.

Hope this answers your questions. Let us know how things go. BY

Choosing medication combination
Have you seen the science community's response to Celia Farber's Harpers article?

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint